A recent study published in France examined intelligence quotient (IQ) in adults with Narcolepsy Type 1 (NT1) and Idiopathic Hypersomnia (IH) disorders using the Wechsler Adult Intelligence Scale (WAIS-IV). Notably, this is the first study to formally assess IQ in adults with IH. Across all three groups (NT1, IH, and healthy controls), participants scored within the normal IQ range, with the IH group averaging slightly higher (114.6) than controls (108.4) and the NT1 group (104.1). Importantly, neither disease duration, daytime sleepiness, nor treatment status had any significant effect on IQ scores. This suggests that chronic hypersomnolence alone does not impair general intellectual functioning.
Beyond the IQ scores themselves, the study uncovered a meaningful distinction between objective performance and subjective experience. While patients in both groups frequently report cognitive complaints such as brain fog and difficulty concentrating, their performance on a comprehensive, standardized IQ test remained intact. Pre-test fatigue, rather than sleepiness, was the only factor linked to lower working memory performance, and this effect was notably absent in the IH group, possibly pointing to compensatory brain mechanisms that help buffer against fatigue-related cognitive decline.
These findings carry important implications for how we support individuals living with NT1 and IH. Despite the real and often invisible challenges these conditions bring (including fatigue, stigma, and psychosocial stress) preserved intellectual functioning means that these individuals retain strong potential for academic and professional achievement. Clinicians, educators, and employers should be aware that cognitive complaints do not equate to cognitive impairment, and that with appropriate accommodations and support, people with NT1 and IH can thrive in demanding environments.
Link to full article: Redirecting